Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

Neuro-Oncology

Disease Sites: Neuro-Oncology

Phase: II

Investigator: Mohler, Alexander

NCTID: NCT05425004

Protocol No: VICC-ITNEU23261

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form